Dr. Kevin Spelman is an internationally recognized expert on the molecular biology and clinical therapeutics of botanical medicines and new product development. A past National Institutes of Health postdoctoral fellow and Marie Curie research fellow in the European Union, he has published 27 scientific papers and 6 chapters. Dr. Spelman has also practiced clinical phytotherapy for 20 years in various medical centers as well as advised the White House Commission on Complementary and Alternative Medicine and most recently was invited to the White House Office of Science and Technology Policy conference on the microbiome. Dr. Spelman has also consulted for the Department of Defense on specific therapeutic outcomes using natural products. Past research projects have included the elucidation of various phytochemicals influencing endocananbinoid signaling, the molecular biology of cannabinoid receptors, and being the first researcher to elucidate cannabinoid ligands in Zanthoxylum spp. Other research has included brain and ovarian cancer, clinical investigations, immunological studies and chemical analysis on multiple medicinal plants. Dr. Spelman is an adjunct assistant professor at Massachusetts College of Pharmacy and Health Sciences, an adjunct professor of botanical medicine at National College of Natural Medicine and a distinguished lecturer at Maryland University of Integrative Health.

Topics discussed:
Functions of terpenes & terpinoids in nature
Physiological effects in humans
Herbal synergy (i.e. The Entourage Effect)
Sativa v. Indica
Safety of inhaling terpenes
Terpenes in concentrates